Results 271 to 280 of about 266,976 (313)
Some of the next articles are maybe not open access.
Current Opinion in Pharmacology, 2005
mTOR kinase plays a central role in the activation of many cell types, and blocking mTOR function with rapamycin results in arrest of the cell cycle at the G1 phase. Recently, several additional molecules have been identified in the mTOR pathway, providing further opportunities to interfere with cell activation and develop novel therapeutic agents ...
Deborah A, Young +1 more
openaire +2 more sources
mTOR kinase plays a central role in the activation of many cell types, and blocking mTOR function with rapamycin results in arrest of the cell cycle at the G1 phase. Recently, several additional molecules have been identified in the mTOR pathway, providing further opportunities to interfere with cell activation and develop novel therapeutic agents ...
Deborah A, Young +1 more
openaire +2 more sources
mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
Hematology/Oncology Clinics of North America, 2012Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase. It is ubiquitously expressed in cells and is a therapeutic target for the cancer treatment arsenal. Despite the great responses obtained in tumors addicted to specific mutations or overactivation of key members of the mTOR pathway (HiF1α in RCC, cyclin D1 in MCL, or TSC in SEGA),
Alejandro, Gomez-Pinillos +1 more
openaire +2 more sources
Science, 2007
A mitochondrial membrane protein links two parts of a signaling pathway that is central to cell growth and proliferation.
openaire +2 more sources
A mitochondrial membrane protein links two parts of a signaling pathway that is central to cell growth and proliferation.
openaire +2 more sources
Diabetes Research and Clinical Practice, 2015
The mammalian target of rapamycin (mTOR) inhibitors are drugs, primarily used as immunosuppressors that are now frequently used as antineoplastic therapies in various cancers (such as advanced renal cell carcinoma, advanced breast cancer, progressive pancreatic neuroendocrine tumors).
Bruno, Vergès, Bertrand, Cariou
openaire +2 more sources
The mammalian target of rapamycin (mTOR) inhibitors are drugs, primarily used as immunosuppressors that are now frequently used as antineoplastic therapies in various cancers (such as advanced renal cell carcinoma, advanced breast cancer, progressive pancreatic neuroendocrine tumors).
Bruno, Vergès, Bertrand, Cariou
openaire +2 more sources
mTOR at the nexus of nutrition, growth, ageing and disease
Nature Reviews Molecular Cell Biology, 2020Grace Y Liu, David M Sabatini
exaly